Evidence to Action: AI-Powered Insights Across the Drug Development Lifecycle
Jun 8, 2026•Channel
AI Analysis
Data from YouTube Data API v3•Updated Just now
Video Overview
Video Details
Published1 month ago
Duration0:38
Video ID-ht_Z39NJgg
Languageen
CategoryScience & Technology
PrivacyPublic
Made for KidsNo
Video TypeYouTube Short
Performance Metrics
Views259
Likes17
Comments1
Engagement Rate6.95%
Likes per 100 views6.56
Comments per 1K views3.86
Video Tags
Description
Every day, the biggest question in life sciences is: Are my decisions backed by solid evidence?
Knolens on Google Cloud is the answer. It's a single, regulatory-grade AI platform spanning the entire life cycle—from clinical trials to regulatory approval, designed to transform raw data into actionable insights, helping you make evidence-backed pharmaceutical decisions faster than ever.
The platform fuses and analyzes complex clinical, regulatory, and payer data, delivering evidence-backed insights that are 100% traceable to their original source. This means zero compromises and a new level of confidence for your team.
With Knolens, you can:
-Avoid LLM Hallucinations: Get reliable, traceable insights without the risk of generative AI errors.
-Achieve Auditability: Gain the confidence required by the FDA and EMA for audit-ready submissions.
-Accelerate Development: Perform complex analysis instantly, significantly boosting speed and efficiency.
-Unify Data: Seamlessly fuse critical clinical, regulatory, and payer data streams.
Ready to turn evidence into action and drastically cut your time-to-submission?
See how Knolens works and visit http://Pienomial.com
#RegulatoryGradeAI, #Knolens, #GoogleCloud, #FDASubmissions, #EvidenceGeneration, #Pharma, #AIinPharma, #DrugDevelopment, #Pharmaceuticals, #RegulatoryAffairs, #Biotech, #ClinicalTrials, #HealthTech, #EvidenceBasedMedicine, #Auditability